Polycomb Repressive Complex 2 (PRC2) methylates lysine 27 in histone H3, a modification associated with epigenetic gene silencing. This complex plays a fundamental role in regulating cellular differentiation and development, and PRC2 overexpression and mutations have been implicated in numerous cancers. In this review, we examine recent studies elucidating the first crystal structures of the PRC2 core complex, yielding seminal insights into its catalytic mechanism, substrate specificity, allosteric regulation, and inhibition by a class of small molecules that are currently undergoing cancer clinical trials. We conclude by exploring unresolved questions and future directions for inquiry regarding PRC2 structure and function.Polycomb group (PcG) proteins represent transcriptional repressors that are present in single cell eukaryotes through multicellular organisms (1,2). The genes encoding many of these proteins were initially characterized in Drosophila as key regulators of epigenetic silencing of homeotic genes (3,4). Subsequent studies demonstrated that PcG proteins function in the context of large heteromeric complexes that repress gene expression within facultative heterochromatin. These PcG complexes include Polycomb Repressive Complexes 1 and 2 (PRC1 and PRC2), as well as the more recently identified Phorepressive Complex (PhoRC) and Polycomb Repressive Deubiquitinase (PR-DUB) (1,5-7). The PRCs possess intrinsic histone modifying activities that contribute to their functions in transcriptional repression. PRC1 monoubiquitinates Lys119 in histone H2A (H2AK119ub1) and can compact chromatin by binding to nucleosomes, whereas PRC2 is a lysine methyltransferase (KMT) that trimethylates Lys27 in histone H3 (H3K27me3), a modification associated with PcG silencing (8-15). PRC1 has been shown to bind H3K27me3, whereas PRC2 can recognize H3K27me3 and H2AK119ub1, facilitating the recruitment of the PRCs to specific genomic loci (16)(17)(18)(19). The interdependence of their enzymatic activities and chromatin localization illustrates how PRC1 and PRC2 can function in concert to epigenetically silence gene expression (20).PRC2 comprises multiple subunits that facilitate its biological functions. The minimal core complex that exhibits methyltransferase activity comprises the core subunits Embryonic Ectoderm Development (EED), Suppressor of Zeste 12 (SUZ12) and the catalytic subunit Enhancer of Zeste Homolog 1 or 2 (EZH1 or EZH2) that possess a conserved catalytic SET domain found in many [21][22][23] (9)(10)(11)20,24,25). Many of these non-core subunits possess intrinsic histone or DNA binding activity and can mediate recruitment of PRC2 to chromatin and promote H3K27 methylation (20,(26)(27)(28)(29). Deletion of the genes encoding the PRC2 core subunits in mice results in morphological defects and embryonic lethality, underscoring their importance in regulating epigenetic programs that are essential to development and differentiation (22,30,31). PRC2 has also been shown to have context-dependent roles in cancer ...